Skip to main content

Acetic acid


Basic information
Metabolite name

Acetic acid

HMDB0000042
C00033
176
Synonyms

Acetate

No. of studies

53

 

Relationship between Acetic acid and depression (count: 53)
Study Study Type Comparison groups Tissue Organism Up/Down regulated
Study M016 Type1 CUMS group vs. control group Urine Sprague-Dawley rat Down
Study M035 Type1 depressed suicide attempters group vs. control group Plasma Human Down
Study M038 Type1 CUMS group vs. control group Urine Sprague-Dawley rat Down
Study M038 Type2 CUMS + low dose of FFCGF group vs. CUMS group Urine Sprague-Dawley rat Up
Study M038 Type2 CUMS + high dose of FFCGF group vs. CUMS group Urine Sprague-Dawley rat Up
Study M038 Type2 CUMS + venlafaxine group vs. CUMS group Urine Sprague-Dawley rat Up
Study M038 Type2 CUMS + middle dose of FFCGF group vs. CUMS group Urine Sprague-Dawley rat Up
Study M038 Type2 CUMS + Xiaoyaosan group vs. CUMS group Urine Sprague-Dawley rat Up
Study M043 Type1 chronic hepatitis B patients with MDD group vs. without MDD group Urine Human Up
Study M077 Type1 non-weaned FST group vs. weaned FST group Urine Wistar rat Up
Study M088 Type3 venlafaxine group vs. control group Faece Wistar rat Down
Study M097 Type1 depressed men group vs. control men group Urine Human Up
Study M1002 Type2 high-fat diet + Faecalibaculum rodentium group vs. high-fat diet group Faece C57Bl6/J mouse Up
Study M1002 Type2 high-fat diet + Xiaoyao San group vs. high-fat diet group Faece C57Bl6/J mouse Up
Study M1003 Type1 CUMS group vs. control group Faece Sprague-Dawley rat Down
Study M1003 Type2 CUMS + Morinda officinalis oligosaccharide group vs. CUMS group Faece Sprague-Dawley rat Up
Study M1003 Type2 CUMS + high dose of alcohol-soluble polysaccharides group vs. CUMS group Faece Sprague-Dawley rat Up
Study M1003 Type2 CUMS + low dose of alcohol-soluble polysaccharides group vs. CUMS group Faece Sprague-Dawley rat Up
Study M1006 Type1 maternal separation group vs. control group Faece C57BL/6J mouse Down
Study M1006 Type2 maternal separation + Bifidobacterium breve CCFM1025 group vs. maternal separation group Faece C57BL/6J mouse Up
Study M1009 Type1 CUMS group vs. control group Faece C57BL/6 mouse Down
Study M1009 Type2 CUMS + multi-probiotics group vs. CUMS group Faece C57BL/6 mouse Up
Study M1016 Type1 CUMS group vs. control group Faece C57BL/6J mouse Down
Study M1016 Type2 CUMS + imipramine group vs. CUMS group Faece C57BL/6J mouse Up
Study M1016 Type2 CUMS + ginsenoside Rh4 group vs. CUMS group Faece C57BL/6J mouse Up
Study M1017 Type1 post-stroke depression group vs. control group Serum C57BL/6j mouse Up
Study M1025 Type2 CUMS + Bacillus licheniformis group vs. CUMS group Faece Sprague-Dawley rat Up
Study M1027 Type1 CUMS group vs. control group Faece Wistar rat Up
Study M1027 Type2 CUMS + low dose of berberine group vs. CUMS group Faece Wistar rat Down
Study M1027 Type2 CUMS + fluoxetine group vs. CUMS group Faece Wistar rat Down
Study M1027 Type2 CUMS + high dose of berberine group vs. CUMS group Faece Wistar rat Down
Study M1042 Type1 CUMS + MCAO group vs. MCAO group Faece Sprague-Dawley rat Down
Study M1048 Type1 juvenile high-fat diet group vs. juvenile control group Brain CD-1 mouse Down
Study M1048 Type1 juvenile high-fat diet group vs. juvenile control group Plasma CD-1 mouse Down
Study M1048 Type2 adult high-fat diet + probiotic group vs. adult high-fat diet group Brain CD-1 mouse Up
Study M1048 Type2 adult high-fat diet + probiotic group vs. adult high-fat diet group Liver CD-1 mouse Down
Study M1048 Type2 adult high-fat diet + probiotic group vs. adult high-fat diet group Plasma CD-1 mouse Down
Study M1048 Type3 adult probiotic group vs. adult control group Brain CD-1 mouse Up
Study M1048 Type3 adult probiotic group vs. adult control group Plasma CD-1 mouse Down
Study M1048 Type3 adult probiotic group vs. adult control group Liver CD-1 mouse Down
Study M1066 Type1 CUMS group vs. control group Kidney Sprague-Dawley rat Up
Study M1066 Type2 CUMS + Xiaoyaosan group vs. CUMS group Kidney Sprague-Dawley rat Down
Study M1066 Type2 CUMS + Shugan group vs. CUMS group Kidney Sprague-Dawley rat Down
Study M1066 Type2 CUMS + Jianpi group vs. CUMS group Kidney Sprague-Dawley rat Down
Study M107 Type1 CORT group vs. control group PC12 cell Rat Up
Study M1086 Type1 CUMS group vs. control group Faece C57BL/6 mouse Down
Study M1087 Type1 CSDS group vs. control group Faece C57BL/6 mouse Down
Study M109 Type1 PPD group vs. HC and PPWD group Urine Human Down
Study M1127 Type2 flavonoid-low orange cordial group, after 8-week treatment vs. baseline Faece Human Up
Study M1127 Type2 flavonoid-rich orange juice group, after 8-week treatment vs. baseline Faece Human Up
Study M1137 Type2 paclitaxel + sodium butyrate group vs. paclitaxel group Faece CD1 mouse Up
Study M1137 Type3 sodium butyrate group vs. control group Faece CD1 mouse Up
Study M134 Type1 CRS group vs. control group Urine Sprague-Dawley rat Down
Study M134 Type2 CRS + BH group vs. CRS group Urine Sprague-Dawley rat Up
Study M146 Type1 CUMS group vs. control group Urine Sprague-Dawley rat Down
Study M146 Type2 CUMS + high dose of SSO group vs. CUMS group Urine Sprague-Dawley rat Up
Study M146 Type2 CUMS + venlafaxine group vs. CUMS group Urine Sprague-Dawley rat Up
Study M475 Type1 dHB group vs. HB group Urine Human Up
Study M492 Type1 ACTH group vs. control group Urine Wistar rat Down
Study M492 Type2 ACTH + memantine group vs. ACTH group Urine Wistar rat Up
Study M492 Type2 ACTH + CGA group vs. ACTH group Urine Wistar rat Up
Study M511 Type1 Susceptible group vs. control group Hippocampus Wistar/ST rat Down
Study M536 Type1 naturally-occurring depression group vs. control group Cerebrospinal fluid Cynomolgus monkey Up
Study M577 Type1 male depression group vs. male control group, aged 30-39 Urine Human Unknown
Study M577 Type1 female depression group vs. female control group, aged 40-49 Plasma Human Unknown
Study M577 Type1 male depression group vs. male control group, aged 20-29 Plasma Human Unknown
Study M589 Type1 current depression group vs. control group Plasma Human Down
Study M614 Type1 CUMS group vs. control group Urine Sprague-Dawley rat Up
Study M629 Type1 CUMS group vs. control group Serum Sprague-Dawley rat Down
Study M629 Type2 CUMS + middle dose of coumaroylspermidine extract group vs. CUMS group Serum Sprague-Dawley rat Up
Study M665 Type1 CRS group vs. control group Faece C57BL/6 mouse Down
Study M667 Type1 CRS group vs. control group Faece C57BL/6 J mouse Down
Study M667 Type2 CRS + crocin-I group vs. CRS group Faece C57BL/6 J mouse Up
Study M680 Type1 5-fluorouracil group vs. control group Prefrontal cortex Sprague-Dawley rat Up
Study M680 Type2 5-fluorouracil + FMT group vs. 5-fluorouracil + sham FMT group Prefrontal cortex Sprague-Dawley rat Down
Study M706 Type2 CUMS + CCFM1025 group vs. CUMS group Faece C57BL/6 mouse Up
Study M707 Type2 CUMS + F45BB group vs. CUMS group Faece C57BL/6J mouse Up
Study M707 Type2 CUMS + S60 group vs. CUMS group Faece C57BL/6J mouse Up
Study M708 Type1 CUMS group vs. control group Faece C57BL/6J mouse Down
Study M739 Type1 CUMS group vs. control group Serum Sprague-Dawley rat Up
Study M778 Type1 LPS group vs. control group Faece C57BL/6J mouse Down
Study M778 Type2 LPS + NU9056 group vs. LPS group Faece C57BL/6J mouse Up
Study M804 Type1 CUMS group vs. control group Faece Sprague-Dawley rat Down
Study M804 Type2 CUMS + high dose of WYJYD group vs. CUMS group Faece Sprague-Dawley rat Up
Study M804 Type2 CUMS + middle dose of WYJYD group vs. CUMS group Faece Sprague-Dawley rat Up
Study M835 Type1 CRS group vs. control group Faece C57BL/6 mouse Down
Study M845 Type1 CRS group vs. control group Faece Mouse Down
Study M872 Type1 CUMS group vs. control group Serum Sprague-Dawley rat Up
Study M872 Type1 CUMS group vs. control group Brain Sprague-Dawley rat Up
Study M886 Type1 lead-exposed group vs. control group Faece Sprague-Dawley rat Down
Study M886 Type2 lead-exposed + probiotics group vs. lead-exposed group Faece Sprague-Dawley rat Up
Study M901 Type1 LPS group vs. control group Faece C57BL/6 mouse Down
Study M901 Type2 LPS + Schisandrin group vs. LPS group Faece C57BL/6 mouse Up
Study M919 Type1 chronic cerebral hypoperfusion group vs. sham group Hippocampus Sprague-Dawley rat Down
Study M919 Type1 chronic cerebral hypoperfusion + FMT from chronic cerebral hypoperfusion group vs. sham operation + FMT from chronic cerebral hypoperfusion group Hippocampus Sprague-Dawley rat Down
Study M919 Type2 chronic cerebral hypoperfusion + FMT from sham group vs. chronic cerebral hypoperfusion + FMT from chronic cerebral hypoperfusion group Hippocampus Sprague-Dawley rat Up
Study M934 Type2 CUS + high-fat diet + 5-hydroxytryptophan group vs. CUS + high-fat diet group Serum C57BL/6J mouse Up
Study M967 Type1 bilateral common carotid artery occlusion group vs. control group Serum Sprague-Dawley rat Down
Study M985 Type2 CUMS + indole acetic acid group vs. CUMS group Cecum C57BL/6J mouse Up
Study M990 Type1 aged microbiota transplant group vs. young microbiota transplant group Faece C57BL/6 mouse Down